Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Fears of diversion allayed somewhat by NIDA buprenorphine study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • المصدر:
    Alcoholism & Drug Abuse Weekly. 10/25/2021, Vol. 33 Issue 41, p1-4. 4p. 1 Chart, 2 Graphs.
  • معلومة اضافية
    • الموضوع:
      SUBSTANCE abuse risk factors; SUBSTANCE abuse; BUPRENORPHINE; FEAR; NATIONAL Institute on Drug Abuse; SELF medication; PHARMACEUTICAL services insurance; DRUG prescribing; PHYSICIAN practice patterns; PAIN management
    • الموضوع:
      UNITED States
    • نبذة مختصرة :
      A study of buprenorphine prescribing for opioid use disorder (OUD) from 2015 to 2019 has found that misuse of the drug decreased during that time period. The study, by researchers from the National Institute on Drug Abuse (NIDA), which funded the development of buprenorphine for OUD, was published last week in JAMA Network Open. [ABSTRACT FROM AUTHOR]
    • نبذة مختصرة :
      Copyright of Alcoholism & Drug Abuse Weekly is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)